{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T14:37:56Z","timestamp":1764859076157},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,5,15]]},"DOI":"10.2169\/internalmedicine.2086-18","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T22:34:49Z","timestamp":1547073289000},"page":"1473-1477","source":"Crossref","is-referenced-by-count":16,"title":["Development of <i>Propionibacterium acnes<\/i>-associated Sarcoidosis During Etanercept Therapy"],"prefix":"10.2169","volume":"58","author":[{"given":"Takuma","family":"Isshiki","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Toho University Omori Medical Centre, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisayo","family":"Matsuyama","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Toho University Omori Medical Centre, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Toho University Omori Medical Centre, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Honma","sequence":"additional","affiliation":[{"name":"Department of Pathology, Toho University Omori Medical Centre, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetuo","family":"Mikami","sequence":"additional","affiliation":[{"name":"Department of Pathology, Toho University Omori Medical Centre, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutoshi","family":"Shibuya","sequence":"additional","affiliation":[{"name":"Department of Pathology, Toho University Omori Medical Centre, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Eishi","sequence":"additional","affiliation":[{"name":"Department of Human Pathology, Tokyo Medical and Dental University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakae","family":"Homma","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Toho University Omori Medical Centre, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Hunninghake GW, Costabel U, Ando M, et al. ATS\/ERS\/WASOG statement on sarcoidosis. American Thoracic Society\/European Respiratory Society\/Wrold Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 16: 149-173, 1999."},{"key":"2","unstructured":"2. Sawahata M, Sugiyama Y, Yamasawa H, et al. Sarcoidosis during etanercept treatment for rheumatoid arthritis in women with a history of bilateral oophorectomy. Sarcoidosis Vasc Diffuse Lung Dis 33: 178-181, 2016."},{"key":"3","unstructured":"3. Daien CL, Monnier A, Claudepierre P, et al. Sarcoid-like granulomatosis in patients with tumor necrosis factor blockers: 10 cases. Rheumatology 48: 883-886, 2009."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Danlos FX, Pages C, Baroudjian B, et al. Nivolumab-induced sarcoid-like granulomatous reaction in a patient with advanced melanoma. Chest 149: e133-e136, 2016.","DOI":"10.1016\/j.chest.2015.10.082"},{"key":"5","unstructured":"5. Reuss JE, Kunk PR, Stowman AM, et al. Sarcoidosis in the settings of combination ipilimumab and nivolumab immunotherapy: a case report & review of the literature. J immunother Cancer 4: 94, 2016."},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Chopra A, Nautiyal A, Kalkanis A, et al. Drug-induced sarcoidosis-like reactions. Chest 154: 664-677, 2018.","DOI":"10.1016\/j.chest.2018.03.056"},{"key":"7","unstructured":"7. Homma JY, Abe C, Chosa H, et al. Bacterial investigation on biopsy specimens from patients with sarcoidosis. Jpn J Exp Med 48: 251-255, 1978."},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Ishige I, Usui Y, Takemura T, et al. Quantitative PCR of mycobacterial and propionibacterial DNA in lymphoid nodes of Japanese patients with sarcoidosis. Lancet 354: 120-123, 1999.","DOI":"10.1016\/S0140-6736(98)12310-3"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Eishi Y, Suga M, Ishige I, et al. Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol 40: 198-204, 2002.","DOI":"10.1128\/JCM.40.1.198-204.2002"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yamada T, Eishi Y, Ikeda S, et al. In situ localization of Propionibacterium acnes DNA in lymph nodes from sarcoidosis patients by signal amplification with catalysed reporter deposition. J Pathol 198: 541-547, 2002.","DOI":"10.1002\/path.1243"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Negi M, Takemura T, Guzman J, et al. Localization of Propionibacterium acnes in granulomas supports a possible etiologic link between sarcoidosis and the bacterium. Mod Pathol 25: 1284-1297, 2012.","DOI":"10.1038\/modpathol.2012.80"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Amiri P, Locksley RM, Paraslow TG, et al. Tumor necrosis factor alpha restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice. Nature 356: 604-607, 1992.","DOI":"10.1038\/356604a0"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Joseph AL, Boros DL. Tumor necrosis fator plays a role in Schistosoma mansoni egg-induced granulomatous inflammation. J Immunol 151: 5461-5471, 1993.","DOI":"10.4049\/jimmunol.151.10.5461"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Lukacs NW, Chensue SW, Strieter RM, et al. Inflammatory granuloma formation is mediated by TNF-alpha-inducible intercellular adhesion molecule-1. J Immunol 152: 5883-5889, 1994.","DOI":"10.4049\/jimmunol.152.12.5883"},{"key":"15","unstructured":"15. Prior C, Knight RA, Herold M, et al. Pulmonary sarcoidosis: patterns in cytokines production. Eur Respir J 9: 47-53, 1996."},{"key":"16","unstructured":"16. Ziegenhagen MW, Bender UK, Zissel G, et al. Sarcoidosis: TNF-\u03b1 release from alveolar macrophages and serum level of sIL-2R are prognostic markers. Am J Respir Crit Care Med 156: 1586-1592, 1997."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Baughman RP, Drent M, Kavuru M, et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 174: 795-802, 2006.","DOI":"10.1164\/rccm.200603-402OC"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kamphuis LS, Lam-Tse WK, Dik WA, et al. Efficacy of adalimumab in chronically active and symptomatic patients with sarcoidosis. Am J Respir Crit Care Med 184: 1214-1216, 2011.","DOI":"10.1164\/ajrccm.184.10.1214"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Ultz JP, Limper AH, Kalra S, et al. Etanercept for the treatment of stage 2 and 3 progressive pulmonary sarcoidosis. Chest 124: 177-185, 2003.","DOI":"10.1378\/chest.124.1.177"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Braun NA, Celada LJ, Herazo-Maya JD, et al. Blockade of the programmed death-1 pathway restores sarcoidosis CD4 (+) T-cell proliferative capacity. Am J Respir Crit Care Med 190: 560-571, 2014.","DOI":"10.1164\/rccm.201401-0188OC"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Miyazaki E, Ando M, Fukami T, et al. Minocycline for the treatment of sarcoidosis: is the mechanism of action immunomodulating or antimicrobial effect? Clin Rheumatol 27: 1195-1197, 2008.","DOI":"10.1007\/s10067-008-0903-3"},{"key":"22","unstructured":"22. Takemori N, Nakamura M, Kojima M, et al. Successful treatment in a case of Propionibacterium acnes-associated sarcoidosis with clarithromycin administration: a case report. J Med Case Rept 8: 15, 2014."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Bachelez H, Senet P, Cadranel J, et al. The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol 137: 69-73, 2001.","DOI":"10.1001\/archderm.137.1.69"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Eishi Y. Etiologic aspect of sarcoidosis as an allergic endogenous infection caused by Propionibacterium acnes. Biomed Res Int 2013 (Epub ahead of print).","DOI":"10.1155\/2013\/935289"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/10\/58_2086-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T20:35:16Z","timestamp":1694550916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/10\/58_2086-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,15]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2086-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,15]]}}}